TaurelFinance, decoded
Live
Loading market data…
TTaurel

Teva climbs premarket as FDA approves once-monthly schizophrenia treatment

Investing.com· Investing.com· Oct 9, 2026 · 12:13 PM
Teva climbs premarket as FDA approves once-monthly schizophrenia treatment

This is a summary. Read the complete story at Investing.com below.

Read full article at Investing.com

Related Stories

Disney moves toward thousands of job cuts, Bloomberg reports
stocksabout 5 hours ago

Disney moves toward thousands of job cuts, Bloomberg reports

Investing.com

Fox’s $22 billion Roku deal poised to clear U.S. antitrust review - Semafor
stocksabout 5 hours ago

Fox’s $22 billion Roku deal poised to clear U.S. antitrust review - Semafor

Investing.com

Earnings beat, guidance raised: our AI-picked pharma stock is up 23.96%
stocksabout 5 hours ago

Earnings beat, guidance raised: our AI-picked pharma stock is up 23.96%

Investing.com